US Federal 2025-2026 Regular Session All Bills (Page 515)

Page 515 of 667
US

US Federal 2025-2026 Regular Session

US Federal Senate Bill SB1041

Introduced
4/10/25  
Introduced
3/13/25  
Refer
3/13/25  
Affordable Prescriptions for Patients ActThis bill limits in certain instances the number of patents that the manufacturer of a biologic drug can assert in a lawsuit against a company seeking to sell a biosimilar version of that drug. (A biologic drug is produced through natural processes or isolated from natural sources. A biosimilar version is substantially similar to the original biologic, which is the reference product, and is often marketed as a less expensive alternative.)The bill's provisions apply to an existing framework that gives the biosimilar manufacturer an abbreviated path to Food and Drug Administration approval to sell the biosimilar. Specifically, if the biosimilar manufacturer completes certain actions under the framework, such as sharing certain information about its product with the reference product manufacturer, the bill limits the number of certain patents that the reference product manufacturer may assert in a lawsuit, such as patents that were filed more than four years after the reference product received market approval. The limit shall not apply to patents claiming certain methods for using the biologic drug.The court in which the infringement lawsuit is filed may increase the limit if justice so requires or if there is good cause for the increase.
US

US Federal 2025-2026 Regular Session

US Federal Senate Bill SB1040

Introduced
4/10/25  
Introduced
3/13/25  
Refer
3/13/25  
Drug Competition Enhancement Act This bill prohibits product hopping by drug manufacturers and authorizes the Federal Trade Commission (FTC) to enforce this prohibition.Generally, product hopping describes a situation where, when the patents on a reference drug (or biological product) expire, the manufacturer switches to a follow-on product that is covered by a later-expiring patent. Under this bill, a follow-on product is a modified version of the reference drug that has an indication (what the drug is used for) that is identical or substantively similar to an indication of the reference drug.The bill establishes a presumption that product hopping has occurred when a reference drug manufacturer, after receiving notice that the Food and Drug Administration has received an application to market a competing generic (or biosimilar) version, takes certain actions such as withdrawing the reference drug from the market and selling a follow-on product.A drug manufacturer may rebut these presumptions by demonstrating that its conduct was not intended to limit competition.The bill makes product hopping an unfair method of competition and provides for enforcement by the FTC. If the FTC has reason to believe a manufacturer has violated or is about to violate this prohibition on product hopping, the FTC may institute an administrative proceeding or bring suit in federal court to stop the manufacturer’s action and seek equitable remedies, including disgorgement of unjust profits or paying restitution to those harmed. 
US

US Federal 2025-2026 Regular Session

US Federal Senate Bill SB1043

Introduced
 
Introduced
3/13/25  
This bill extends the energy investment tax credit for qualified fuel cell property for eight years.Under current law, an energy investment tax credit of up to 30% of the cost of qualified fuel cell property is available provided construction of the qualified fuel cell property begins on or before December 31, 2024. This bill extends the energy investment tax credit to include qualified fuel cell property where construction begins on or before December 31, 2032.
US

US Federal 2025-2026 Regular Session

US Federal Senate Bill SB1048

Introduced
 
Introduced
3/13/25  
Connecting Small Businesses with Career and Technical Education Graduates ActThis bill includes within the responsibilities of Small Business Development Centers and Women's Business Centers the provision of assistance to small businesses in hiring graduates from career and technical education programs and to graduates of such programs in starting small businesses.
US

US Federal 2025-2026 Regular Session

US Federal Senate Bill SB1047

Introduced
4/1/25  
Introduced
3/13/25  
Refer
3/13/25  
A bill to prohibit individuals convicted of defrauding the Government from receiving any assistance from the Small Business Administration, and for other purposes.
US

US Federal 2025-2026 Regular Session

US Federal Senate Bill SB1053

Introduced
 
Introduced
3/13/25  
Foreign Investment Guardrails to Help Thwart China Act of 2025 or FIGHT China Act of 2025 This bill authorizes sanctions on certain foreign persons (individuals and entities) that are involved with China's defense or surveillance technology sectors. The bill also requires U.S. persons to notify the Department of the Treasury about their investments with certain foreign persons in various technologies, and (2) authorizes Treasury to prohibit U.S. persons from making investments with such foreign persons in some of these technologies.  Specifically, the President is authorized to impose property-blocking sanctions on certain foreign persons (including members of the Chinese Communist Party Central Committee, Chinese businesses, Chinese governmental entities, and businesses with equity securities primarily traded on Chinese stock exchanges) that Treasury determines to be knowingly engaged in significant operations in China's defense, defense-related material, or surveillance technology sectors.  Additionally, the bill authorizes Treasury to bar U.S. persons from knowingly engaging in certain transactions (such as acquiring an equity interest, providing a loan, or entering into a joint venture) with most of these categories of foreign persons if they involve a prohibited technology. Prohibited technologies include those thatdevelop a quantum computer; develop, design, or produce materials, components, or systems for hypersonic systems; ordevelop, design, or produce artificial intelligence models for use by the Chinese government.Treasury must require U.S. persons to notify Treasury if they engage in such transactions involving a range of technologies, including the prohibited technologies.
US

US Federal 2025-2026 Regular Session

US Federal Senate Bill SB1054

Introduced
 
Introduced
3/13/25  
A bill to abolish the United States African Development Foundation.
US

US Federal 2025-2026 Regular Session

US Federal Senate Bill SB1056

Introduced
 
Introduced
3/13/25  
A bill to establish a home-based telemental health care grant program for purposes of increasing mental health and substance use services in rural medically underserved populations and for individuals in farming, fishing, and forestry occupations
US

US Federal 2025-2026 Regular Session

US Federal Senate Bill SB1055

Introduced
 
Introduced
3/13/25  
Indian Health Service Emergency Claims Parity ActThis bill extends from 72 hours to 15 days the time period to notify the Purchased/Referred Care (PRC) program of emergency medical care received from a non-Indian Health Service (IHS) medical provider or at a non-IHS medical facility. This bill does not apply to individuals who are elderly or disabled, who continue to have a 30-day notification requirement for emergency services.The IHS provides medical and dental services directly to American Indian and Alaska Native patients whenever possible. The PRC program pays for medical or dental care that is provided away from an IHS or tribal health care facility. The PRC program must be notified of requests for authorization of payment for health care services from a non-IHS provider.Currently in emergency cases, the patient, an individual on behalf of the patient, or the medical care provider must, within 72 hours after the beginning of treatment for the condition or after admission to a health care facility, notify a PRC authorizing official of the need for the emergency medical care. This bill instead allows the patient, other individual, or provider to notify PRC within 15 days of the treatment or admission.
US

US Federal 2025-2026 Regular Session

US Federal Senate Bill SB105

Introduced
10/2/25  
Introduced
1/15/25  
Refer
1/15/25  
Wounded Knee Massacre Memorial and Sacred Site Act This bill directs the Department of the Interior to complete all actions necessary to place approximately 40 acres of land in Oglala Lakota County, South Dakota, into restricted fee status for the Oglala Sioux Tribe and the Cheyenne River Sioux Tribe. Restricted fee status refers to land that is owned by a tribe or tribal member but is subject to restrictions by the United States against alienation (i.e., sale or transfer) or encumbrance (e.g., liens, leases, or rights-of-way) by operation of law. The bill requires the land to be held and maintained as a memorial and sacred site, as outlined by the document titled Covenant Between the Oglala Sioux Tribe and the Cheyenne River Sioux Tribe and dated October 21, 2022. Further, it prohibits commercial development and gaming activity on the land.
US

US Federal 2025-2026 Regular Session

US Federal Senate Bill SB107

Introduced
 
Introduced
1/16/25  
Lumbee Fairness Act This bill extends federal recognition to the Lumbee Tribe of North Carolina and makes its members eligible for the services and benefits provided to members of federally recognized tribes. Members of the tribe residing in Robeson, Cumberland, Hoke, and Scotland Counties in North Carolina are deemed to be within the delivery area for such services. The Department of the Interior and the Department of Health and Human Services must develop, in consultation with the tribe, a determination of needs to provide the services for which members of the tribe are eligible. Interior may take land into trust for the benefit of the tribe. Finally, North Carolina must exercise jurisdiction over all criminal offenses committed, and all civil actions that arise, on North Carolina lands owned by, or held in trust for, the Lumbee Tribe or any dependent Indian community of the tribe unless jurisdiction is transferred to the United States pursuant to an agreement between the tribe and the state.
US

US Federal 2025-2026 Regular Session

US Federal Senate Bill SB1080

Introduced
 
Introduced
3/14/25  
A bill to amend the Internal Revenue Code of 1986 to exclude from gross income certain federally subsidized loan repayments for dental school faculty.
US

US Federal 2025-2026 Regular Session

US Federal Senate Bill SB1081

Introduced
9/8/25  
Introduced
3/14/25  
Refer
3/14/25  
Comprehensive NASA Reporting Act of 2025This bill sets forth general requirements for the submission of reports and notices to Congress by the National Aeronautics and Space Administration (NASA). The bill also requires NASA to provide Congress with a copy of any international agreement or nonbinding instrument entered into by the United States that concerns NASA’s activities in space. 
US

US Federal 2025-2026 Regular Session

US Federal Senate Bill SB1087

Introduced
 
Introduced
3/14/25  
Rebuild America’s Health Care Schools Act of 2025This bill allows hospitals to receive reimbursement under Medicare for certain costs associated with training nursing and allied health students in settings other than the hospital itself. Currently, hospitals may receive reimbursement under Medicare for the reasonable costs associated with training nursing and allied health students if certain conditions are met; the criteria vary depending on whether the students are enrolled in an educational program that is operated by the hospital or another entity. If the students are part of a program that is operated by another entity, the training must occur at the hospital itself or in areas immediately surrounding the hospital in order to qualify for reimbursement (among other requirements). The bill allows hospitals to receive reimbursement for these costs if the training is conducted at an entity that is related to the hospital (i.e., common ownership or control).The bill requires the Centers for Medicare & Medicaid Services (CMS) to update regulations to reflect these changes. Additionally, the CMS may not recoup or reduce payments to hospitals with respect to costs that are allowed under the bill and must refund any such recoupments or reductions that occurred during the six-year period prior to the bill's enactment.
US

US Federal 2025-2026 Regular Session

US Federal Senate Bill SB1086

Introduced
 
Introduced
3/14/25  
A bill to amend the Immigration and Nationality Act to prohibit the admission of Chinese nationals as nonimmigrant students, and for other purposes.